Furthermore, increased expression of COL6A1 has been linked to enhanced motility and metastasis in lung, pancreatic, and cervical cancer cells, whereas reducing COL6A1 expression has been associated with decreased metastatic capabilities [23, 24]. Here, COL6A1 is linked to cervical carcinoma.